Read articles from Global

June 10, 2026 by substack.com

How vaping scare stories are made

Vaping scare stories often begin with selective framing rather than balanced evidence. When studies are reported without proper context on relative risk, exposure levels or comparisons with smoking, public understanding can quickly become distorted. This matters because exaggerated risk perception may discourage adult smokers from switching to lower-risk alternatives. Better health communication should inform the public accurately, not turn complex evidence into fear-driven headlines.

June 09, 2026 by substack.com

Is it ethical to prohibit nicotine products?

Prohibiting non-combustible nicotine products risks protecting cigarettes rather than public health. When lower-risk alternatives are restricted or banned, adult smokers may be left with fewer realistic options to move away from combustible tobacco. Effective nicotine policy should distinguish between use and harm, prioritising reduced exposure, accurate risk communication and proportionate regulation.

June 08, 2026 by thecable.ng

Beyond smoke: Why ‘one switch, everyone wins’ is reframing the global tobacco debate

The global tobacco debate is shifting from nicotine abstinence to harm reduction. For adult smokers, switching from combustible cigarettes to lower-risk alternatives could mean fewer smoking-related harms and more realistic pathways to quitting. The “One Switch, Everyone Wins” approach reframes tobacco policy around evidence, choice and practical public health outcomes.

June 08, 2026 by junonews.com

WHO hit with community fact check after calling for flavoured vape bans

WHO Director-General Tedros Adhanom Ghebreyesus called for global action against tobacco and nicotine companies, citing high youth usage rates. Despite a fact check dispute on the impact of vaping on youth, the WHO advocates for banning flavored vaping products, regulating advertising, and controlling packaging to combat addiction.

June 04, 2026 by time.com

To Quit Smoking, I Started Hiking

Despite decades of public health campaigns, smoking remains stubbornly persistent. Around 10% of American adults still smoke cigarettes, while millions more use e-cigarettes and other nicotine products. Nicotine is among the most addictive substances known, altering the brain’s reward pathways and making quitting notoriously difficult. Most people who smoke want to stop. Many try repeatedly before they succeed.

June 03, 2026 by nypost.com

Vaping messes with genes linked to cancer and disease — and the flavor you choose makes a difference: study

Vaping, once seen as a safe cigarette alternative, is now linked to health risks like gene changes promoting diseases. Fruit-flavored vapes alter over 3,000 genes, affecting cancer and other conditions. Different devices and flavors play a role, with mods and mixed flavors causing more gene alterations. While e-cigarettes affect muscles and breathing negatively, issues like cancer are also highlighted. The American Heart Association warns of the dangers, stressing the addictive nature of nicotine and its impact on young users' developing brains. Regulators need to consider the health risks associated with vaping carefully.

June 02, 2026 by drinkanddrugsnews.com

Tobacco harm reduction guide for drug services launched

Drug and alcohol services are encouraged to make smoking reduction a routine part of harm reduction support. Smoking rates among people in treatment remain far higher than in the general population, creating a major but often overlooked health inequality. Safer nicotine products are presented as practical tools that can help people reduce or stop smoking without requiring immediate nicotine abstinence. Integrating tobacco harm reduction into drug services could offer a low-cost, high-impact way to improve health outcomes for people facing multiple disadvantages. The guide calls for more realistic, compassionate support that meets people where they are and gives them better options than continued smoking.

June 02, 2026 by drinkanddrugsnews.com

Tobacco harm reduction guide for drug services launched

Drug and alcohol services are encouraged to make smoking reduction a routine part of harm reduction support. Smoking rates among people in treatment remain far higher than in the general population, creating a major but often overlooked health inequality. Safer nicotine products are presented as practical tools that can help people reduce or stop smoking without requiring immediate nicotine abstinence. Integrating tobacco harm reduction into drug services could offer a low-cost, high-impact way to improve health outcomes for people facing multiple disadvantages. The guide calls for more realistic, compassionate support that meets people where they are and gives them better options than continued smoking.

June 02, 2026 by filtermag.org

World Health Organization Misses the Whole Point About Nicotine Pouches

The World Health Organization’s approach to nicotine pouches is criticised for focusing on nicotine use rather than the far greater health risks of smoking. Nicotine pouches are presented as a lower-risk, smoke-free alternative that can help adults move away from combustible cigarettes. Concerns about youth marketing are acknowledged, but strong restrictions, flavour bans and high taxes may make these products less accessible to adults who smoke. Canada is used as an example of how strict regulation can encourage illicit markets, where products are not age-gated and may contain higher nicotine levels. A more effective approach would regulate nicotine pouches responsibly while recognising their potential role in reducing smoking-related disease.

June 01, 2026 by businesstech.co.za

Study shows loved ones benefit when smokers switch to non-combustible alternatives

Switching from cigarettes to non-combustible nicotine alternatives is linked not only to benefits for smokers, but also to improvements for the people closest to them. Loved ones reported better quality of life, improved emotional wellbeing and more positive shared experiences when smokers moved to products such as vapes, heated tobacco or nicotine pouches. The findings suggest that harm reduction can have wider household and social benefits, including less exposure to smoke, fewer unpleasant smells and improved relationships. Support for adult access to safer nicotine alternatives was high across the countries surveyed, especially among those who had seen someone quit smoking with these products. Policies that treat vaping and smoking in the same way risk ignoring the very different risk profiles of these products and the real-life benefits reported by smokers and their families.